Open access · OA
via OpenAlex
Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers
Jürgen Hetzel, Bernd Balletshofer, Kilian Rittig, Daniel Walcher, Wolfgang Kratzer, Vinzenz Hombach, Hans‐Ulrich Häring, Wolfgang Köenig, Nikolaus Marx
Arteriosclerosis Thrombosis and Vascular Biology · 2005 · ▲ 137 citations
Abstract
BACKGROUND: Antidiabetic thiazolidinediones (TZDs), like rosiglitazone or pioglitazone, improve endothelial function in patients with type 2 diabetes or metabolic syndrome, but it is currently unknown, whether these beneficial effects of TZDs depend on their metabolic action or may be caused by direct effects on the endothelium. Therefore, the present study examined whether short-term rosiglitazone treatment influences endothelium-dependent vasodilation as well as serum levels of vascular disease biomarkers in healthy, nondiabetic subjects. METHODS AND RESULTS: Short-term treatment (21 days) of healthy subjects (n = 10) did not significantly change blood glucose levels or lipid profile. In contrast, rosiglitazone significantly increased flow-mediated, endothelium-dependent vasodilation already within the first day from 5.3+/-2.7% at baseline to 7.8+/-2.6%, further increasing it to 9.4+/-3.0% at day 21. In addition, the early improvement of endothelium-dependent vasodilation was paralleled by a rapid reduction of serum levels of the biomarkers C-reactive protein (CRP), serum amyloid A (SAA), and sE-selectin. Moreover, after drug withdrawal all markers remained suppressed for the whole follow-up period of 7 days. In contrast, rosiglitazone treatment did not significantly affect tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, sICAM-1, sVCAM-1, and sCD40L levels. CONCLUSIONS: Our study suggests a direct effect of TZD treatment on endothelial function and inflammatory biomarkers of arteriosclerosis, promoting the concept that TZDs, independent of their metabolic action, may exhibit protective effects in the vessel wall.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1161/01.atv.0000176192.16951.9a
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Hetzel, J., Balletshofer, B., Rittig, K., Walcher, D., Kratzer, W., Hombach, V., Häring, H., Köenig, W., & Marx, N. (2005). Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers. <em>Arteriosclerosis Thrombosis and Vascular Biology</em>. https://doi.org/10.1161/01.atv.0000176192.16951.9a
Vancouver
Hetzel J, Balletshofer B, Rittig K, Walcher D, Kratzer W, Hombach V, et al. Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers. Arteriosclerosis Thrombosis and Vascular Biology. 2005. doi:10.1161/01.atv.0000176192.16951.9a.
BibTeX
@article{jrgen2005RapidE,
title = {Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers},
author = {Jürgen Hetzel and Bernd Balletshofer and Kilian Rittig and Daniel Walcher and Wolfgang Kratzer and Vinzenz Hombach and Hans‐Ulrich Häring and Wolfgang Köenig and Nikolaus Marx},
journal = {Arteriosclerosis Thrombosis and Vascular Biology},
year = {2005},
doi = {10.1161/01.atv.0000176192.16951.9a},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Fatima Jinnah Medical University 2022
Open access · CC-BY
Correlation of inflammatory biomarkers with disease severity in hospitalised patients of COVID-19 at presentation
BMC Oral Health 2021
Open access · CC-BY
Salivary inflammatory biomarkers and glycated haemoglobin among patients with type 2 diabetic mellitus
The University of Texas Health Science Center at San Antonio 2020
Open access · US-GOV
Effect of SGLT2 Inhibition on Aging-related Biomarkers in Older Obese Adults With Pre-diabetes
The American Journal of Medicine 2010
Open access · OA
Serum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective Study
World Journal of Diabetes 2017
Open access · CC-BY
Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study
Age and Ageing 2024
Open access · CC-BY